LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
24h
Current
Min
298.91
Max
313.64
Income | 31M 125M |
|---|---|
Sales | 97M 1.4B |
Profit margin | 8.84 |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +24.63% upside |
Market Cap | 22B |
|---|---|
Previous open | 312.86 |
Previous close | 310.16 |
By Acuity
50%
50%
165 / 374 Ranking in Healthcare
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
17 lis 2025, 12:16 UTC
Zymeworks, Jazz Pharmaceuticals Shares Rise Following Positive Phase 3 Results for Cancer Treatment
DJ
Read
12 maj 2025, 02:16 UTC
Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs
DJ
Read
29 sty 2025, 15:59 UTC
ImmunityBio Shares Rise After Collaboration, Supply Agreement With BeiGene
DJ
Read
14 gru 2025, 08:30 UTC
Kymera Had a Big Week. This Secretive Hedge Fund Bought $172 Million of Its Stock. -- Barrons.com
DJ
Read
6 lis 2025, 11:01 UTC
BeOne Medicines Sees FY25 Rev $5.1B-$5.3B >ONC
DJ
Read
6 lis 2025, 11:01 UTC
BeOne Medicines 3Q Adj EPS $2.65 >ONC
DJ
Read
6 lis 2025, 11:01 UTC
BeOne Medicines 3Q Rev $1.4B >ONC
DJ
Read
6 lis 2025, 11:00 UTC
BeOne Medicines 3Q EPS $1.09 >ONC
DJ
Read
6 sie 2025, 10:01 UTC
BeOne Medicines Narrows FY25 View To Rev $5.0B-$5.3B >ONC
DJ
Read
6 sie 2025, 10:01 UTC
BeOne Medicines 2Q Rev $1.3B >ONC
DJ
Read
6 sie 2025, 10:01 UTC
BeOne Medicines 2Q Adj EPS $2.25 >ONC
DJ
Read
6 sie 2025, 10:00 UTC
BeOne Medicines 2Q EPS 84c >ONC
DJ
Read
9 lip 2025, 09:17 UTC
Stocks to Watch Wednesday: Freeport-McMoRan, Glencore, Novo Nordisk -- WSJ
DJ
Read
7 maj 2025, 10:07 UTC
BeiGene Maintains 2025 Expense Guidance of $4.1B to $4.4B >ONC
DJ
Read
7 maj 2025, 10:06 UTC
BeiGene Backs 2025 Rev $4.9B-$5.3B >ONC
DJ
Read
7 maj 2025, 10:05 UTC
BeiGene 1Q Net $1.27M >ONC
DJ
Read
7 maj 2025, 10:04 UTC
BeiGene Says to Rename Company to BeOne Medicines >ONC
DJ
Read
7 maj 2025, 10:02 UTC
BeiGene 1Q EPS $0.00 >ONC
DJ
Read
7 maj 2025, 10:02 UTC
BeiGene 1Q Rev Increased 49% >ONC
DJ
Read
7 maj 2025, 10:00 UTC
BeiGene 1Q Rev $1.12B >ONC
DJ
Read
27 lut 2025, 11:07 UTC
BeiGene Sees 2025 Rev $4.9B-$5.3B >ONC
DJ
Read
27 lut 2025, 11:06 UTC
BeiGene 4Q Global BRUKINSA Rev of $828M >ONC
DJ
Read
27 lut 2025, 11:06 UTC
BeiGene 4Q Loss/Shr 11c >ONC
DJ
Read
27 lut 2025, 11:06 UTC
BeiGene 4Q Rev $1.13B >ONC
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 397.66 USD 24.63%
High 424 USD
Low 362 USD
Based on 13 Wall Street analysts offering 12 month price targets forBeOne Medicines Ltd ADR - Dist in the last 3 months.
By TipRanks
Strong Buy
13 ratings
12
Buy
1
Hold
0
Sell
Based on 13 analysts giving stock ratings to BeOne Medicines Ltd ADR - Dist in the past 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Operating profit
$